Simple blood tests may spot early aging signs in pets

Credibility

Interest

Key Takeaway

Routine blood test patterns can estimate a dog’s age and differences from that estimate may flag early signs of age-related health problems.

What They Found

Researchers looked at regular blood test results from many Labrador retrievers and found that certain blood values change predictably as dogs get older. They used 24 common blood measurements and many simple ratios to build a computer model that could guess a dog’s age with an average error of about 14.6 months. The model noticed clear shifts in several blood values around middle age (3–6 years) and older age (around 12 years). When a dog’s predicted age was more than six months older than its real age, those dogs were more likely to get common age-related problems soon after, like arthritis, lumps, eye changes called nuclear sclerosis, and liver issues. This means regular, standard blood tests might show signs of faster or slower biological ageing before clear symptoms appear.

Who Should Care and Why

MS patients and caregivers can take two lessons from this dog study even though it’s about pets: first, routine simple blood tests can reveal hidden signs of aging or health risk, just like a check engine light can warn you before a breakdown. Second, a gap between 'predicted' and actual age may point to higher near-term risk of conditions, so paying attention to small lab changes could lead to earlier care. Caregivers who manage routine testing for someone with MS might use the idea to ask clinicians whether regular blood patterns are being tracked over time, not just single test results. Healthcare providers can consider using patterns in routine labs to spot early changes and adjust monitoring or treatments sooner. MS patients with mobility, pain, or fatigue who worry about new problems could benefit from more attention to regular basic labs as part of their ongoing care plan.

Important Considerations

This study used data from healthy Labrador retrievers, not people, so results don’t transfer directly to humans with MS. The model estimates ‘biological age’ from lab patterns, but that is an indirect sign and not a definite diagnosis—clinicians still need to connect lab changes with symptoms and other tests. Also, the prediction error (about 14.6 months) and study limits mean these lab signals are helpful as a prompt for closer checks, not as a standalone proof of disease.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Diagnostics MS Progression

Article Topics:

BloodDogEpidemiologyHealth

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like GeroScience often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News